S1 Ep240: AMCP Nexus 2023 - Recap on Biosimilar Updates
Nov 03, 2023•7 min•Season 1Ep. 240
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
On this month's episode, Pharmacy Times covers the Academy of Managed Care Pharmacy Nexus 2023 conference, highlighting the updates on biosimilars. Interviews include: Chelsee Jensen, PharmD, BCPS a senior pharmacy specialist and pharmaceutical formulary manager at Mayo Clinic, Prerakkumar Parikh, PharmD, director of Specialty Clinical Solutions at Magellan Rx Management, and Kimberly Maxfield, PhD, from the FDA.
For more Nexus 2023 coverage, visit pharmacytimes.com.
Key Takeaways:
For more Nexus 2023 coverage, visit pharmacytimes.com.
Key Takeaways:
- Jensen discusses biosimilar approval updates, trends biosimilars, and what health care professionals can expect in the future.
- Parikh discusses the impact of interchangeable biosimilars, their cost-saving benefits, and the influx of biosimilars into pharmacy.
- Maxfield discusses the role pharmacists can take to reassure patients when switching to a biosimilar and the future of biosimilar development.
For the best experience, listen in Metacast app for iOS or Android